EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 23 / No 3 (May-June 2016) OCL, 23 3 (2016) D306 References
Open Access
Issue
OCL
Volume 23, Number 3, May-June 2016
Article Number D306
Number of page(s) 10
Section Dossier: Lipid consumption and functionality: new perspectives / Consommations et fonctionnalités des lipides : nouveaux horizons
DOI https://doi.org/10.1051/ocl/2016009
Published online 25 March 2016
  • Amar J, Burcelin R, et al. 2008. Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 87: 1219–1223. [Google Scholar]
  • Bazil V, Strominger JL. 1991. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 147: 1567–1574. [PubMed] [Google Scholar]
  • Blackwell TS, Christman JW. 1996. Sepsis and cytokines: current status. British J. Anaesthesia 77: 110–117. [CrossRef] [Google Scholar]
  • Bourlieu C, Michalski MC. 2015. Structure-function relationship of the milk fat globule. Curr. Opin. Clin. Nutr. Metab. Care 18: 118–127. [Google Scholar]
  • Cani PD, Delzenne NM. 2010. Impact du microbiote intestinal sur la perméabilité intestinale et les désordres métaboliques liés à l’obésité. Louvain Med. 129: S8–10. [Google Scholar]
  • Cani PD, Amar J, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761–1772. [CrossRef] [PubMed] [Google Scholar]
  • Cani PD, Bibiloni R, et al. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470–1481. [CrossRef] [PubMed] [Google Scholar]
  • Cani PD, Rottier O, et al. 2008. Changes in gut microbiota control intestinal permeability-induced inflammation in obese and diabetic mice through unexpected dependent mechanisms. Diabetologia 51: S34–S35. [Google Scholar]
  • Clemente-Postigo M, Queipo-Ortuno MI, et al. 2012. Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J. Lipid Res. 53: 973–978. [Google Scholar]
  • Creely SJ, McTernan PG, et al. 2007. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292: E740–E747. [Google Scholar]
  • De Courten B, Moreno-Navarrete JM, et al. 2016. Contrasting association of circulating sCD14 with insulin sensitivity in non-obese and morbidly obese subjects. Mol. Nutr. Food Res. 60: 103–109. [CrossRef] [PubMed] [Google Scholar]
  • De La Serre CB, Ellis CL, et al. 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G440–448. [CrossRef] [PubMed] [Google Scholar]
  • Deopurkar R, Ghanim H, et al. 2010. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 33: 991–997. [CrossRef] [PubMed] [Google Scholar]
  • Ding S, Lund PK. 2011. Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 14: 328–333. [CrossRef] [PubMed] [Google Scholar]
  • Eichbaum EB, Harris HW, et al. 1991. Chylomicrons can inhibit endotoxin activity in vitro. J. Surg. Res. 51: 413–416. [Google Scholar]
  • Erridge C, Attina T, et al. 2007. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86: 1286–1292. [CrossRef] [PubMed] [Google Scholar]
  • Fernandez-Real JM, Perez del Pulgar S, et al. 2011. CD14 modulates inflammation-driven insulin resistance. Diabetes 60: 2179–2186. [CrossRef] [PubMed] [Google Scholar]
  • Frazier TH, DiBaise JK, et al. 2011. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J. Parent. Enteral Nutr. 35: 14S–20S. [CrossRef] [Google Scholar]
  • Furet J-P, Kong L-C, et al. 2010. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59: 3049–3057. [CrossRef] [PubMed] [Google Scholar]
  • Gallay P, Barras C, et al. 1994. Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS. J. Infect. Dis. 170: 1319–1322. [Google Scholar]
  • Gallier S, Vocking K, et al. 2015. A novel infant milk formula concept: Mimicking the human milk fat globule structure. Colloids Surf. B 136: 329–339. [Google Scholar]
  • Gautier T, Klein A, et al. 2008. Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice. J. Biol. Chem. 283: 18702–18710. [Google Scholar]
  • Ghanim H, Abuaysheh S, et al. 2009. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32: 2281–2287. [CrossRef] [PubMed] [Google Scholar]
  • Ghanim H, Sia CL, et al. 2010. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am. J. Clin. Nutr. 91: 940–949. [CrossRef] [PubMed] [Google Scholar]
  • Ghoshal S, Witta J, et al. 2009. Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 50: 90–97. [CrossRef] [Google Scholar]
  • Gummesson A, Carlsson LM, et al. 2011. Intestinal permeability is associated with visceral adiposity in healthy women. Obesity (Silver Spring) 19: 2280–2282. [CrossRef] [PubMed] [Google Scholar]
  • Hailman E, Lichenstein HS, et al. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179: 269–277. [Google Scholar]
  • Harris HW, Grunfeld C, et al. 1993. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J. Clin. Invest. 91: 1028–1034. [Google Scholar]
  • Harris HW, Rockey DC, et al. 1998. Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats. Hepatology 27: 1341–1348. [CrossRef] [PubMed] [Google Scholar]
  • Harte AL, Varma MC, et al. 2012. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care 35: 375–382. [CrossRef] [PubMed] [Google Scholar]
  • Hiki N, Berger D, et al. 1999. Changes in endotoxin-binding proteins during major elective surgery: Important role for soluble CD14 in regulation of biological activity of systemic endotoxin. Clin. Diagn. Lab. Immunol. 6: 844–850. [Google Scholar]
  • Kelly CJ, Colgan SP, et al. 2012. Of microbes and meals: the health consequences of dietary endotoxemia. Nutr. Clin. Practice 27: 215–225. [CrossRef] [Google Scholar]
  • Kemp DM, 2013. Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota? Adipocyte 2: 188–190. [CrossRef] [PubMed] [Google Scholar]
  • Lakatos PL, Kiss LS, et al. 2011. Serum Lipopolysaccharide-binding Protein and Soluble CD14 Are Markers of Disease Activity in Patients with Crohn’s Disease. Inflamm. Bowel Dis. 17: 767–777. [Google Scholar]
  • Lamping N, Dettmer R, et al. 1998. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J. Clin. Invest. 101: 2065–2071. [CrossRef] [PubMed] [Google Scholar]
  • Lassenius MI, Pietilainen KH, et al. 2011. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 34: 1809–1815. [CrossRef] [PubMed] [Google Scholar]
  • Laugerette F, Vors C, et al. 2011. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J. Nutr. Biochem. 22: 53–59. [Google Scholar]
  • Laugerette F, Furet JP, et al. 2012. Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. Am. J. Physiol. Endocrinol. Metab. 302: E374–386. [CrossRef] [PubMed] [Google Scholar]
  • Laugerette F, Alligier M, et al. 2014. Overfeeding increases postprandial endotoxemia in men: Inflammatory outcome may depend on LPS transporters LBP and sCD14. Mol. Nutr. Food Res. 58: 1513–1518. [Google Scholar]
  • Laugerette F, Pineau G, et al. 2015. Endotoxemia analysis by the Limulus amoebocyte lysate assay in different mammal species used in metabolic studies J. Anal. Bioanalytical Tech., final revision. [Google Scholar]
  • Le Chatelier ENT, Qin J, Prifti E, et al. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 29: 541–546. [CrossRef] [PubMed] [Google Scholar]
  • Lecomte M, Bourlieu C, et al. 2015. Milk Polar Lipids Affect In Vitro Digestive Lipolysis and Postprandial Lipid Metabolism in Mice. J. Nutr. 145: 1770–1777. [Google Scholar]
  • Lecomte M, Couedelo L, et al. 2016. Dietary emulsifiers from milk and soybean differently impact adiposity and inflammation in association with modulation of colonic goblet cells in high-fat fed mice. Mol. Nutr. Food Res. DOI:10.1002/mnfr.201500703. [Google Scholar]
  • Ley RE. 2010. Obesity and the human microbiome. Curr. Opin. Gastroenterol. 26: 5–11. [CrossRef] [PubMed] [Google Scholar]
  • Ley RE, Turnbaugh PJ, et al. 2006. Microbial ecology – Human gut microbes associated with obesity. Nature 444: 1022–1023. [CrossRef] [PubMed] [Google Scholar]
  • Libby P. 2002. Inflammation in atherosclerosis. Nature 420: 868–874. [CrossRef] [PubMed] [Google Scholar]
  • Lundman P, Boquist S, et al. 2007. A high-fat meat is accompanied by increased plasma interleukin-6 concentrations. Nutr. Metab. Cardiovasc. Diseas. 17: 195–202. [CrossRef] [Google Scholar]
  • Magné J, Mariotti F, et al. 2010. Early postprandial low-grade inflammation after high-fat meal in healthy rats: possible involvement of visceral adipose tissue. J. Nutr. Biochem. 21: 550–555. [CrossRef] [Google Scholar]
  • Mani V, Hollis JH, et al. 2013. Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia. Nutr. Metab. 10: 6. [CrossRef] [Google Scholar]
  • Marshall JC, 2005. Lipopolysaccharide: an endotoxin or an exogenous hormone? Clin. Infect. Dis. 41: S470–480. [CrossRef] [PubMed] [Google Scholar]
  • Mathison JC, Tobias PS, et al. 1992. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J. Immunol. 149: 200–206. [PubMed] [Google Scholar]
  • Matsushita H, Ohta S, et al. 2010. Endotoxin tolerance attenuates airway allergic inflammation in model mice by suppression of the T-cell stimulatory effect of dendritic cells. Int. Immunol. 22: 739–747. [Google Scholar]
  • Michalski MC, Genot C, et al. 2013. Multiscale structures of lipids in foods as parameters affecting fatty acid bioavailability and lipid metabolism. Progress Lipid Res. 52: 354–373. [CrossRef] [Google Scholar]
  • Moreno-Navarrete JM, Escote X, et al. 2013. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia 56: 2524–2537. [CrossRef] [PubMed] [Google Scholar]
  • Nappo F, Esposito K, et al. 2002. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals. J. Am. College Cardiol. 39: 1145–1150. [CrossRef] [Google Scholar]
  • Neal MD, Leaphart C, et al. 2006. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J. Immunol. 176: 3070–3079. [CrossRef] [PubMed] [Google Scholar]
  • Osborn MJ, Rosen SM, et al. 1964. Lipopolysaccharide of the Gram-Negative Cell Wall. Science 145: 783–789. [CrossRef] [PubMed] [Google Scholar]
  • Pais de Barros JP, Gautier T, et al. 2015. Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay. J. Lipid Res. 56: 1363–1369. [CrossRef] [PubMed] [Google Scholar]
  • Pastor Rojo O, Lopez San Roman A., et al. 2007. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm. Bowel Dis. 13: 269–277. [Google Scholar]
  • Ross R, 1999. Atherosclerosis is an inflammatory disease. Am. Heart J. 138: S419–420. [Google Scholar]
  • Schiffrin EJ, Parlesak A, et al. 2009. Probiotic yogurt in the elderly with intestinal bacterial overgrowth: endotoxaemia and innate immune functions. Br. J. Nutr. 101: 961–966. [CrossRef] [PubMed] [Google Scholar]
  • Sussman M. 2002. Academic: San Diego, CA. [Google Scholar]
  • Tobias PS, Mathison J, et al. 1992. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am. J. Respiratory Cell Mol. Biol. 7: 239–245. [CrossRef] [Google Scholar]
  • Van Dielen FM, van’t Veer C, et al. 2001. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int. J. Obes. Relat. Metab. Disord. 25: 1759–1766. [Google Scholar]
  • Vors C, Gayet-Boyer C, et al. 2014. Produits laitiers et inflammation métabolique : quels liens en phase postprandiale et à long terme? Cah. Nutr. Diet. 50: 25–38. [Google Scholar]
  • Vors C, Pineau G, et al. 2015. Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial. J. Clin. Endocrinol. Metab. 100: 3427–3435. [CrossRef] [PubMed] [Google Scholar]
  • Vreugdenhil AC, Rousseau CH, et al. 2003. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J. Immunol. 170: 1399–1405. [Google Scholar]
  • Wurfel MM, Kunitake ST, et al. 1994. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180: 1025–1035. [CrossRef] [PubMed] [Google Scholar]
  • Zhang HS, DiBaise JK, et al. 2009. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. USA 106: 2365–2370. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.